廣田聡

ヒロタアキラ | HIROTA Akira

研究分野 (1件)：医化学

競争的資金等の研究課題 (2件)：

論文 (4件)：

Akira Hirota, Jean-Emmanuel Clément, Satoshi Tanikawa, Takayuki Nonoyama, Tamiki Komatsuzaki, Jian Ping Gong, Shinya Tanaka, Masamichi Imajo. ERK MAP Kinase Signaling Regulates RAR Signaling to Confer Retinoid Resistance on Breast Cancer Cells. Cancers. 2022. 14. 23. 5890-5890
Hirota, A., AlMusawi, S., Nateri, A.S., Ordóñez-Morán, P., Imajo, M. Biomaterials for intestinal organoid technology and personalized disease modeling. Acta Biomaterialia. 2021. 132
Hirota, A., Nakajima-Koyama, M., Ashida, Y., Nishida, E. The nucleosome remodeling and deacetylase complex protein CHD4 regulates neural differentiation of mouse embryonic stem cells by down-regulating p53. Journal of Biological Chemistry. 2019. 294. 1. 195-209
Ashida, Y., Nakajima-Koyama, M., Hirota, A., Yamamoto, T., Nishida, E. Activin A in combination with ERK1/2 MAPK pathway inhibition sustains propagation of mouse embryonic stem cells. Genes to Cells. 2017. 22. 2. 189-202

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

廣田 聡